Measuring Quality of Life in Patients with Schizophrenia: An Update von Awad, A. George, Voruganti, Lakshmi N.P.

Volltext

Chlorpromazine versus placebo for schizophrenia von Adams, Clive E, Awad, George A, Rathbone, John, Thornley, Ben, Soares‐Weiser, Karla, Adams, Clive E

Volltext

The Impact of Newer Atypical Antipsychotics on Patient-Reported Outcomes in Schizophrenia von Awad, A. George, Voruganti, Lakshmi N. P.

Volltext

Revisiting the Concept of Subjective Tolerability to Antipsychotic Medications in Schizophrenia and its Clinical and Research Implications: 30 Years Later von Awad, A. George

Volltext

Does treatment adherence correlates with health related quality of life? Findings from a cross sectional study von Saleem, Fahad, Hassali, Mohamed Azmi, Shafie, Asrul Akmal, Awad, George A, Atif, Muhammad, ul Haq, Noman, Aljadhey, Hisham, Farooqui, Maryam

Volltext

The Burden of Schizophrenia on Caregivers: A Review von Awad, A. George, Voruganti, Lakshmi N. P.

Volltext

Validation of a clinician questionnaire to assess reasons for antipsychotic discontinuation and continuation among patients with schizophrenia von Matza, Louis S, Phillips, Glenn A, Revicki, Dennis A, Ascher-Svanum, Haya, Malley, Karen G, Palsgrove, Andrew C, Faries, Douglas E, Stauffer, Virginia, Kinon, Bruce J, George Awad, A, Keefe, Richard S.E, Naber, Dieter

Volltext

Is it time to consider comorbid substance abuse as a new indication for antipsychotic drug development? von Awad, A George

Volltext

A Conceptual Model of Quality of Life in Schizophrenia: Description and Preliminary Clinical Validation von GEORGE AWAD, A, VORUGANTI, L.N.P, HESLEGRAVE, R.J

Volltext

Chlorpromazine for schizophrenia: a Cochrane systematic review of 50 years of randomised controlled trials von Adams, Clive Elliott, Rathbone, John, Thornley, Ben, Clarke, Mike, Borrill, Jo, Wahlbeck, Kristian, Awad, A George

Volltext

Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: data from a randomized double-blind trial von Gharabawi, Georges M, Greenspan, Andrew, Rupnow, Marcia F T, Kosik-Gonzalez, Colette, Bossie, Cynthia A, Zhu, Young, Kalali, Amir H, Awad, A George

Volltext

Methodological Issues in Negative Symptom Trials von MARDER, Stephen R, DANIEL, David G, ALPHS, Larry, AWAD, A. George, KEEFE, Richard S. E

Volltext

Is Neuroleptic Dysphoria a Variant of Drug-Induced Extrapyramidal Side Effects? von Voruganti, Lakshmi P, Awad, A George

Volltext

Psychometric evaluation of the Medication Satisfaction Questionnaire (MSQ) to assess satisfaction with antipsychotic medication among schizophrenia patients von Vernon, Margaret K, Revicki, Dennis A, Awad, A. George, Dirani, Riad, Panish, Jessica, Canuso, Carla M, Grinspan, Augusto, Mannix, Sally, Kalali, Amir H

Volltext

Impact of atypical antipsychotics on quality of life in patients with schizophrenia von AWAD, A. George, VORUGANTI, Lakshmi N. P

Volltext

Revisiting the ‘self-medication’ hypothesis in light of the new data linking low striatal dopamine to comorbid addictive behavior von Awad, A. George, Voruganti, Lakshmi L.N.P.

Volltext

Personal evaluation of transitions in treatment (PETiT):a scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia von Voruganti, Lakshmi N.P, Awad, A.George

Volltext

Subjective and behavioural consequences of striatal dopamine depletion in schizophrenia — Findings from an in vivo SPECT study von Voruganti, Lakshmi N.P., Awad, A. George

Volltext

Measuring Quality of Life in Patients with Schizophrenia von Awad, A. George, Voruganti, Lakshmi N.P

Volltext

New generation antipsychotic drugs and compliance behaviour von Voruganti, Lakshmi P, Baker, Laura K, Awad, A George

Volltext